title: Preparation of a novel floating ring capsule-type dosage form for stomach specific delivery.
abstract: Study objectives were to develop a unique floating ring capsule dosage form which combines gastric soluble and insoluble portions, and to evaluate its suitability for stomach specific drug delivery. New floating ring capsules were developed using different polymers and were compared for various parameters. The formulation with HPMC and sodium CMC has better floating properties. The effects of polymers concentration on drug release were studies by in vitro release studies. The interaction studies of combined drug with polymers were determined using FT-IR spectroscopy. The entrapped air within the gel barrier and lower densities of HPMC and sodium CMC resulted in better floating behavior. Steady slow gel formations showed prolonged drug release. The in vitro release rates were generally found to be faster with low concentration of carbopol showing release within 2 h, while formulations containing high amount of HPMC showed release in 8 h. In particular, the higher concentration of HPMC formulation shows the best drug release performance. A very low change in peak shift was observed only with sodium alginate formulations. Further, FT-IR measurements confirmed the absence of any chemical interactions. Results indicate that new floating ring capsule is a promise dosage form for stomach specific delivery.
authors: Department of Pharmaceutical Technology, Y.B. Chavan College of Pharmacy, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India.
authors: Md Ismail
authors: MI
authors: Mouzam
authors: M H G
authors: MH
authors: Dehghan
authors: Shaikh
authors: S
authors: Asif
authors: Trupti
authors: T
authors: Sahuji
authors: Pooja
authors: P
authors: Chudiwal
keywords: In vitro drug release; New floating ring capsule; Polymers; Stomach specific delivery
references: Drug Dev Ind Pharm. 2002 Apr;28(4):443-9
references: 12056537
references: J Control Release. 2000 Feb 3;63(3):235-59
references: 10601721
references: Int J Pharm. 2003 Mar 6;253(1-2):13-22
references: 12593933
references: AAPS PharmSciTech. 2007 Feb 23;8(1):14
references: 17408214
references: J Pharm Sci. 1961 Oct;50:874-5
references: 13907269
references: AAPS PharmSciTech. 2010 Sep;11(3):1119-27
references: 20635228
references: J Pharm Sci. 1967 Oct;56(10):1238-42
references: 6059440
references: Vision Res. 2010 Mar 31;50(7):680-5
references: 19854210
references: J Pharm Sci. 1983 Oct;72(10):1189-91
references: 6644570
references: Arch Pharm Res. 2009 Dec;32(12):1767-74
references: 20162406
references: J Control Release. 2004 Feb 20;95(1):101-8
references: 15013237
references: Dig Dis Sci. 1992 May;37(5):769-72
references: 1563322
references: Dtsch Med Wochenschr. 1981 Sep 4;106(36):1143-7
references: 7261941
references: Pharm Res. 1986 Aug;3(4):208-13
references: 24271583
references: J Pharm Sci. 1963 Dec;52:1145-9
references: 14088963
references: Am J Gastroenterol. 2006 Sep;101(9):1985-90
references: 16968503
references: Adv Drug Deliv Rev. 2001 Jun 11;48(2-3):139-57
references: 11369079
references: Helicobacter. 2006 Oct;11 Suppl 1:36-9
references: 16925610
references: Pharm Acta Helv. 1985;60(4):110-1
references: 4011621
references: Pharm Sci Technol Today. 2000 Jun;3(6):198-204
references: 10840390
references: AAPS PharmSciTech. 2006 May 26;7(2):E47
references: 16796364
references: Lancet. 1994 Jan 22;343(8891):243-4
references: 7904707